• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

FUNCTIONAL ANALYSIS AND MODIFICATION OF NOVEL MACROLACTAM ANTITUMOR ANTIBIOTIC

Research Project

Project/Area Number 11480160
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Bioorganic chemistry
Research InstitutionTOKYO INSTITUTE OF TECHNOLOGY

Principal Investigator

KAKINUMA Katsumi  TOKYO INSTITUTE OFTECHNOLOGY, GRADUATE SCHOOL OF SCIENCE AND ENGINEERING, PROFESSOR, 大学院・理工学研究科, 教授 (90092543)

Project Period (FY) 1999 – 2000
KeywordsMacrolactam / Antitumor Antibiotic / Aminosugar / Polyketide / Total Synthesis / Vicenistatin / Cytotoxicity
Research Abstract

A novel 20-membered macrolactam glycoside antibiotic was studied based on its interesting chemotherapeutic activity against human solid tumors. To get some insight into the molecular basis of its function, search for related products, total synthesis, chemical modification, simplification and biosynthetic studies were carried out. A total synthesis was completed by developing a new synthetic method of vicenisamine and related aminosugars from non-carbohydrate starting materials and by constructing the macrolactam aglycon from (S)-citronellol by using Suzuki-cross coupling and asymmetric aldol reactions as key step. The fermentation of the producing organism Streptomyces sp. HC-34 was further screened and a new analog, named as vicenistatin M having a neutral sugar D-mycarose instead of vicenisamine aminosugar, was isolated. A key finding with vicenistatin M was that an aminosugar is essential for the antitumor activities. The structure was ultimately determined by its total synthesis. … More Chemically synthesized kedarosamine, a key aminosugar of antibiotic kedarcidin Chromophore, was transglycosylated to the vicenistatin aglycon and the resulting 4'-epi-vicenistatin and 4'-epi-α-vicenistatin was found to have slightly reduced cytotoxic activity. Important observation in the structural simplification studies was that 3,7-dimethyloctyl β-vicenisaminide showed a comparable intense cytotoxicity to vicenistatin. Methylation of the amide nitrogen of the aglycon induced conformational flipping of the vicenistatin aglycon, the cytotoxicity of which was reduced to 1/40. Apparently. the conformation of the aglycon plays a significant role for the activity. Fluorescence labeling was also attempted by introducing a pyrenyl function into visenisamine or the amide function. To improve the solubility of vienistatin, a lactone aglycon rather than a lactam was totally synthesized and further elaboration to vicenisaminide aglycon has been continued. The biosyrthesis pathway of vicenistatin was elucidated by isotope-tracer technology. A key feature is the formation of the starter unit of the polyketide aglycon that involves a stereospecific molecular rearrangement of glutamic acid into 3-methylaspartic acid. Less

  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] T.Eguchi: "Unique Solvent-dependent Atropisomerism of A Novel Cytotoxit Naphthoxanthene Antibiotic FD-594"J.Org.Chem.. 64[15]. 5371-5376 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Matsushima: "Enantioselective Synthesis of Vicenistatin, A Novel 20-Membered Macrocyclic Lactam Antitumor Antibiotic"Abstract of the 217th ACS National Meeting. March. ORGN-67 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Ito: "A Novel Fungal Metabolite NG-061 Enhances and Mimics Neutrophic effect of Nerve Growth Factor (NGF) on Neurite Outgrowth in PC12 Cells"J.Antibiotics. 52[3]. 224-230 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] R.Bhandari: "Structure of NG-061, A Novel Potentiator of Nerve Growth Factor (NGF) Isolated from Penicillium miniolutem F4647"J.Antibiotics. 52[3]. 231-234 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] K.Kakinuma: "Vicenistatin"季刊化学総説. 45. 261-262 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] M.Otsuka: "Biosynthetic Pathway of Macrolactam Polyketide Glycoside Antitumor Antibiotic Vicenistatins"Tetrahedron. 56[42]. 8281-8286 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] T.Eguihi: "Synthesis of NG-061 and Its Analysis, and Their Biological Evaluation as an Enhancer of Nerve Growth Factor"Chem.Pharm.Bull.. 48[10]. 1470-1473 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Matsushima: "Isolation and Structure Elucidation of Vicenistatin M, and Importance of the Vicenisamine Aminosugar for Exerting Cytotoxicity of Vicenistatin"J.Antibiotics. 54[3]. 211-219 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Matsushima: "Versatile Route to 2,6-Dideoxyamino Sugars from Non-sugar Materials : Synthesis of Vicenisamine and Kedaro samine"J.Chem.Soc.Perkin Trans.I. [6]. 569-577 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Matsushima, S.Horiuchi, T.Nakayama, H.Ito, T.Eguchi, K.Kakinuma.: "Enantioselective Synthesis of Vicenistatin. A Novel 20-Membered Macrocyclic Lactam Antitumor Antibiotic"217th ACS National Meeting (1999) Anaheim, CA.USA. ORGN-67

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Eguchi, K.Kondo, K.Kakinuma, H.Uekusa, Y.Ohashi, K.Mizoue, Y.-F.Qiao: "Unique Solvent-dependent Atropisomerism of A Novel Cytotoxic Naphthoxanthene Antibiotic FD-594"J.Org.Chem.. 64 [15]. 5371-5376 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Ito, N.Sakai, K.Ito, F.Mizobe, K.Hanada, K.Mizoue R.Bhandari, T.Eguchi, K.Kakinuma: "A Novel Fungal Metabolite NG-061 Enhances and Mimics Neurotrophic Effect of Nerve Growth Factor (NGF) on Neurite Outgrowth in PC12 Cells"J.Antibiot.. 52 [3]. 224-230 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] R.Bhandari, T.Eguchi, A.Sekine, Y.Ohashi, K.Kakinuma: "Structure of NG-061, A Novel Potentiator of Nerve Growth Factor (NGF) Isolated from Penicillium miniolutem F-4647"J.Antibiot.. 52 [3]. 231-234 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] M.Otsuka, M.Fujita, Y.Matsushima, T.Eguchi, K.Shindo, K.Kakinuma: "Biosynthetic Pathway of Macro-Lactam Polyketide Glycoside Antitumor Antibiotic Vicenistatins"Tetrahedron. 56 [42]. 8281-8286 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Eguchi, S.Kanai, K.Kakinuma, T.Okazaki, K.Mizoue: "Synthesis of NG-061 and Its Analogs, and Their Biological Evaluation as an Enhancer of Nerve Growth Factor."Chem.Pharm.Bull.. 48 [10]. 1470-1473 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Matsushima, T.Nakayama, M.Fujita, R.Bhandari, T.Eguchi, K.Shindo, K.Kakinuma: "Isolation and Structure Elucidation of Vicenistatin M, and Importance of the Vicenisamine Aminosugar for Exerting Cytotoxicity of Vicenistatin."J.Antibiot.. 54 [3]. 211-219 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Matsushima, T.Nakayama, S.Toyama, T.Eguchi, K.Kakinuma: "Versatile Route to 2,6-Dideoxyamino Sugars from Non-sugar Materials : Syntheses of Vicenisamine and Kedarosamine"J.Chem.Soc.Perkin I. 2001 [6]. 569-577 (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi